Sort by
Refine Your Search
-
London (UCL). The project aims to develop personalized antisense oligonucleotide (ASO) therapy for beta-propeller protein-associated neurodegeneration (BPAN), a rare early onset disorder affecting neuronal
Enter an email to receive alerts for "UCL " positions